c137

AI 3-63044 is a bioactive chemical.

CBL0137 hydrochloride (Curaxin-137 hydrochloride) is an inhibitor of the histone chaperone FACT, which also activates p53 and inhibits NF-κB with EC50 values ​​of 0.37 and 0.47 μM, respectively. CBL0137 hydrochloride functionally inactivates the complex that promotes chromatin transcription (FACT), thereby driving effects on p53 and NF-κB and promoting cancer cell death, and when used in combination with cisplatin, CBL0137 hydrochloride has potent anticancer activity against SCLC.

MAC13772 is a potent inhibitor of the enzyme BioA with an IC50 of 250 nM, thereby inhibiting biotin biosynthesis and exhibiting antibacterial activity.

1-(2-Pyridyl)piperazine (NSC-13778) is a selective α2-adrenoceptor antagonists. 1-(2-Pyridyl)piperazine shows sympatholytic activity. 1-(2-Pyridyl)piperazine is also a metabolite of Azaperone.

Cefpimizole sodium is a Semisynthetic cephalosporin with antibacterial activity.

Cefpimizole is a broad-spectrum caphalosporin antibiotic with limited side effects and high efficacy.

CZC-13788 is a highly potent and selective H4R antagonist with the potential utility in the treatment of inflammatory diseases.

Lanuginosine, an aporphine alkaloid, exhibits cytotoxicity against U251.

CBL0137 (Curaxin 137), a metabolically stable curaxin, activates p53 (EC50: 0.37 μM) and inhibits NF-κB (EC50: 0.47 μM). It functionally inactivates the facilitates chromatin transcription complex (FACT), driving the effects on p53 and NF-κB and promoting cancer cell death. CBL0137 has broad anticancer activity in mice when administered orally, eradicates drug-resistant cancer stem cells, and potentiates the efficacy of gemcitabine in preClinicalal models of pancreatic cancer.

VPC-13789 is a highly potent, selective, and orally bioavailable antiandrogen compound that shows promise for studying and developing therapeutics for castration-resistant prostate cancer (CRPC). In LNCaP cells, VPC-13789 effectively inhibits the transcriptional activity of the androgen receptor (AR) with an IC50 value of 0.19 μM [1].

(-)-Dizocilpine maleate ((-)-MK 801 (Maleate)) is a potent, selective, and non-competitive NMDA receptor antagonist, with a Kd of 37.2 nM in rat brain membranes.

YC-137 is a BCL-2 inhibitor, which selectively induces apoptosis of Bcl-2-overexpressing cells and disrupts its interaction with Bid BH3, thereby blocking the anti-apoptotic activity of Bcl-2.

NSC-13755 is a human flap endonuclease 1 (FEN1) inhibitor.

P60v-src(137-157) is a synthetic peptide that inhibits the tyrosine kinase activity of p60 v-src, with an IC50 of 7.5 μM [1] [2].

TCMDC-137332 is a compound exhibiting antimalarial activity against Plasmodium falciparum with an IC50 value of 7 nM, and can be utilized for malaria research [1].